CHIASMA, INC

NEEDHAM, MA How do I update this listing?

Chiasma is based out of Needham. Chiasma, Inc. operates as a biopharmaceutical company. The Company develops pharmaceutical products for the treatment of acromegaly and hormonal disorders. Chiasma offers its products in the United States.Whalewisdom has at least 57 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-03-05. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security

Create Alert

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-03-05 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 87,153,480 69,722,786 17,430,694
2014-12-24 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 56,250,000 33,774,763 22,475,237
2012-07-23 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 38,659,507 10,026,669 28,632,838
2012-06-07 D BIOTECHNOLOGY Debt 3,038,335 3,038,335 0
2011-07-01 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 23,350,000 5,115,000 18,235,000
2011-06-14 D/A BIOTECHNOLOGY Debt 10,000,000 10,000,000 0
2011-03-09 D/A BIOTECHNOLOGY Debt 9,000,000 9,000,000 0
2011-01-06 D/A BIOTECHNOLOGY Debt 6,000,000 5,000,000 1,000,000
2010-07-22 D BIOTECHNOLOGY Debt 4,000,000 2,000,000 2,000,000
2009-11-24 D BIOTECHNOLOGY Debt 4,800,000 2,800,000 2,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANSBERT K. GADICKE subscription required
    DIRECTOR
BARD J. GEESAMAN subscription required
    EXECUTIVE OFFICER DIRECTOR
BENJAMIN T. SPORN subscription required
    EXECUTIVE OFFICER
CHAIME ORLEV subscription required
    EXECUTIVE OFFICER
DALIA MEGIDDO subscription required
    DIRECTOR
DAVID M. STACK subscription required
    DIRECTOR
DROR BRANDWEIN subscription required
    DIRECTOR
FREDRIC D. PRICE subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN A. SCARLETT subscription required
    DIRECTOR
ROBERT CITRON subscription required
    EXECUTIVE OFFICER
RONI MAMLUK subscription required
    EXECUTIVE OFFICER
SAM TEICHMAN subscription required
    EXECUTIVE OFFICER
SCOTT MINICK subscription required
    DIRECTOR
TODD T. FOLEY subscription required
    DIRECTOR
VINCENT MILES subscription required
    DIRECTOR

Elevate your investments